Jackson Wealth Management LLC boosted its holdings in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 48.8% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 14,623 shares of the company's stock after purchasing an additional 4,796 shares during the period. Jackson Wealth Management LLC's holdings in Procter & Gamble were worth $2,330,000 at the end of the most recent reporting period.
Several other hedge funds have also added to or reduced their stakes in PG. Nova Wealth Management Inc. purchased a new position in shares of Procter & Gamble in the first quarter valued at about $26,000. Signature Resources Capital Management LLC increased its position in shares of Procter & Gamble by 67.9% in the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company's stock valued at $28,000 after acquiring an additional 72 shares during the period. Quarry LP purchased a new position in shares of Procter & Gamble in the first quarter valued at about $33,000. Mizuho Securities Co. Ltd. increased its position in shares of Procter & Gamble by 566.7% in the first quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company's stock valued at $34,000 after acquiring an additional 170 shares during the period. Finally, Quest 10 Wealth Builders Inc. increased its position in shares of Procter & Gamble by 50.3% in the first quarter. Quest 10 Wealth Builders Inc. now owns 245 shares of the company's stock valued at $42,000 after acquiring an additional 82 shares during the period. 65.77% of the stock is owned by institutional investors.
Wall Street Analysts Forecast Growth
A number of equities analysts have issued reports on the stock. UBS Group set a $180.00 price objective on shares of Procter & Gamble and gave the company a "buy" rating in a research report on Wednesday, July 30th. JPMorgan Chase & Co. reissued a "neutral" rating and issued a $170.00 price target (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Barclays decreased their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating for the company in a research note on Wednesday. Weiss Ratings reissued a "hold (c+)" rating on shares of Procter & Gamble in a research note on Saturday, September 27th. Finally, Evercore ISI reissued an "in-line" rating and issued a $170.00 price target (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Eleven analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $173.11.
View Our Latest Research Report on Procter & Gamble
Insider Transactions at Procter & Gamble
In other news, CEO Jon R. Moeller sold 40,119 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The shares were sold at an average price of $157.27, for a total value of $6,309,515.13. Following the transaction, the chief executive officer owned 319,375 shares in the company, valued at approximately $50,228,106.25. This represents a 11.16% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, CFO Andre Schulten sold 11,638 shares of the company's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $1,830,308.26. Following the completion of the transaction, the chief financial officer owned 52,642 shares in the company, valued at approximately $8,279,007.34. This represents a 18.11% decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 120,181 shares of company stock valued at $18,918,012. 0.20% of the stock is currently owned by insiders.
Procter & Gamble Price Performance
Shares of PG opened at $152.19 on Friday. The stock has a market cap of $356.20 billion, a PE ratio of 23.38, a price-to-earnings-growth ratio of 4.01 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a quick ratio of 0.49 and a current ratio of 0.70. Procter & Gamble Company has a fifty-two week low of $149.91 and a fifty-two week high of $180.43. The firm's 50-day simple moving average is $155.51 and its two-hundred day simple moving average is $160.06.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. The business had revenue of $20.89 billion for the quarter, compared to analysts' expectations of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business's revenue was up 1.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.
Procter & Gamble Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, August 15th. Stockholders of record on Friday, July 18th were paid a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 2.8%. The ex-dividend date was Friday, July 18th. Procter & Gamble's dividend payout ratio is currently 64.98%.
About Procter & Gamble
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.